Market revenue in 2023 | USD 336.7 million |
Market revenue in 2030 | USD 563.7 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.8% in 2023. Horizon Databook has segmented the Netherlands formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The Netherlands is one of the most advanced countries in Europe in terms of healthcare & pharmaceutical sectors, with top drug manufacturers such as Pfizer and Abbvie. There is also a substantial presence of CROs and CDMOs, which cater to the needs of pharmaceutical & biotech companies.
Many of these outsourcing providers are expanding their geographical footprint worldwide, which is anticipated to increase the demand for formulation development services. Furthermore, medical and healthcare spending in the country has increased in recent years, reflecting potential opportunities for innovative drug manufacturing.
In addition, the burden of chronic diseases in the country is raising the requirements for effective therapeutic drugs in the market, thereby improving the adoption rate of drug formulation development outsourcing.
Horizon Databook provides a detailed overview of country-level data and insights on the Netherlands formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Netherlands formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account